nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—Electrocardiogram change—Salbutamol—chronic obstructive pulmonary disease	0.038	0.038	CcSEcCtD
Nitrofurantoin—Benign intracranial hypertension—Prednisolone—chronic obstructive pulmonary disease	0.0212	0.0212	CcSEcCtD
Nitrofurantoin—Muscle atrophy—Prednisone—chronic obstructive pulmonary disease	0.0192	0.0192	CcSEcCtD
Nitrofurantoin—Liver disorder—Montelukast—chronic obstructive pulmonary disease	0.0165	0.0165	CcSEcCtD
Nitrofurantoin—Benign intracranial hypertension—Prednisone—chronic obstructive pulmonary disease	0.0154	0.0154	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.0116	0.0116	CcSEcCtD
Nitrofurantoin—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.0116	0.0116	CcSEcCtD
Nitrofurantoin—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.0101	0.0101	CcSEcCtD
Nitrofurantoin—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00934	0.00934	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0092	0.0092	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.00907	0.00907	CcSEcCtD
Nitrofurantoin—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00894	0.00894	CcSEcCtD
Nitrofurantoin—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00891	0.00891	CcSEcCtD
Nitrofurantoin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00844	0.00844	CcSEcCtD
Nitrofurantoin—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00834	0.00834	CcSEcCtD
Nitrofurantoin—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00784	0.00784	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00737	0.00737	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00737	0.00737	CcSEcCtD
Nitrofurantoin—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.00736	0.00736	CcSEcCtD
Nitrofurantoin—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00722	0.00722	CcSEcCtD
Nitrofurantoin—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00722	0.00722	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00722	0.00722	CcSEcCtD
Nitrofurantoin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00712	0.00712	CcSEcCtD
Nitrofurantoin—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00707	0.00707	CcSEcCtD
Nitrofurantoin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00703	0.00703	CcSEcCtD
Nitrofurantoin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.007	0.007	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00698	0.00698	CcSEcCtD
Nitrofurantoin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00692	0.00692	CcSEcCtD
Nitrofurantoin—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00682	0.00682	CcSEcCtD
Nitrofurantoin—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00671	0.00671	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00667	0.00667	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00662	0.00662	CcSEcCtD
Nitrofurantoin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.0064	0.0064	CcSEcCtD
Nitrofurantoin—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00639	0.00639	CcSEcCtD
Nitrofurantoin—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00631	0.00631	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00625	0.00625	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00618	0.00618	CcSEcCtD
Nitrofurantoin—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00608	0.00608	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00596	0.00596	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00596	0.00596	CcSEcCtD
Nitrofurantoin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0058	0.0058	CcSEcCtD
Nitrofurantoin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00566	0.00566	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00563	0.00563	CcSEcCtD
Nitrofurantoin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00554	0.00554	CcSEcCtD
Nitrofurantoin—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00544	0.00544	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00543	0.00543	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0054	0.0054	CcSEcCtD
Nitrofurantoin—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00536	0.00536	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00535	0.00535	CcSEcCtD
Nitrofurantoin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00535	0.00535	CcSEcCtD
Nitrofurantoin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00531	0.00531	CcSEcCtD
Nitrofurantoin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00531	0.00531	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.0052	0.0052	CcSEcCtD
Nitrofurantoin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00514	0.00514	CcSEcCtD
Nitrofurantoin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00514	0.00514	CcSEcCtD
Nitrofurantoin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0051	0.0051	CcSEcCtD
Nitrofurantoin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00507	0.00507	CcSEcCtD
Nitrofurantoin—Chills—Salbutamol—chronic obstructive pulmonary disease	0.0049	0.0049	CcSEcCtD
Nitrofurantoin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00481	0.00481	CcSEcCtD
Nitrofurantoin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00475	0.00475	CcSEcCtD
Nitrofurantoin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Nitrofurantoin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00468	0.00468	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Nitrofurantoin—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Nitrofurantoin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00457	0.00457	CcSEcCtD
Nitrofurantoin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Nitrofurantoin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Nitrofurantoin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00448	0.00448	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00441	0.00441	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00441	0.00441	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00439	0.00439	CcSEcCtD
Nitrofurantoin—Cough—Formoterol—chronic obstructive pulmonary disease	0.00439	0.00439	CcSEcCtD
Nitrofurantoin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00439	0.00439	CcSEcCtD
Nitrofurantoin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00435	0.00435	CcSEcCtD
Nitrofurantoin—Cough—Montelukast—chronic obstructive pulmonary disease	0.0043	0.0043	CcSEcCtD
Nitrofurantoin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Nitrofurantoin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Nitrofurantoin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Nitrofurantoin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Nitrofurantoin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Nitrofurantoin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.00427	CcSEcCtD
Nitrofurantoin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00427	0.00427	CcSEcCtD
Nitrofurantoin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00427	0.00427	CcSEcCtD
Nitrofurantoin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00423	0.00423	CcSEcCtD
Nitrofurantoin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00423	0.00423	CcSEcCtD
Nitrofurantoin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.0042	0.0042	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00416	0.00416	CcSEcCtD
Nitrofurantoin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00415	0.00415	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Nitrofurantoin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Nitrofurantoin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Nitrofurantoin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Nitrofurantoin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00394	0.00394	CcSEcCtD
Nitrofurantoin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00389	0.00389	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00388	0.00388	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00378	0.00378	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Nitrofurantoin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Nitrofurantoin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00369	0.00369	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Nitrofurantoin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Nitrofurantoin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Nitrofurantoin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00365	0.00365	CcSEcCtD
Nitrofurantoin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00365	0.00365	CcSEcCtD
Nitrofurantoin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Nitrofurantoin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Nitrofurantoin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Nitrofurantoin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Nitrofurantoin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00355	0.00355	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00355	0.00355	CcSEcCtD
Nitrofurantoin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00354	0.00354	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Nitrofurantoin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Nitrofurantoin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Nitrofurantoin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00348	0.00348	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00347	0.00347	CcSEcCtD
Nitrofurantoin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Nitrofurantoin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00345	0.00345	CcSEcCtD
Nitrofurantoin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00342	0.00342	CcSEcCtD
Nitrofurantoin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Nitrofurantoin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0034	0.0034	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Nitrofurantoin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Nitrofurantoin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Nitrofurantoin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00335	0.00335	CcSEcCtD
Nitrofurantoin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00332	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Nitrofurantoin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Nitrofurantoin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Nitrofurantoin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Nitrofurantoin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00325	0.00325	CcSEcCtD
Nitrofurantoin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Nitrofurantoin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Nitrofurantoin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Nitrofurantoin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Nitrofurantoin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Nitrofurantoin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Nitrofurantoin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Nitrofurantoin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Nitrofurantoin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00302	0.00302	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00296	0.00296	CcSEcCtD
Nitrofurantoin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Nitrofurantoin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.0029	0.0029	CcSEcCtD
Nitrofurantoin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Nitrofurantoin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Nitrofurantoin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Nitrofurantoin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00278	0.00278	CcSEcCtD
Nitrofurantoin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00275	CcSEcCtD
Nitrofurantoin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nitrofurantoin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nitrofurantoin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00266	0.00266	CcSEcCtD
Nitrofurantoin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00265	CcSEcCtD
Nitrofurantoin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00261	0.00261	CcSEcCtD
Nitrofurantoin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.00261	CcSEcCtD
Nitrofurantoin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00259	0.00259	CcSEcCtD
Nitrofurantoin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00259	0.00259	CcSEcCtD
Nitrofurantoin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Nitrofurantoin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00257	0.00257	CcSEcCtD
Nitrofurantoin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Nitrofurantoin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Nitrofurantoin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Nitrofurantoin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00252	0.00252	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00248	0.00248	CcSEcCtD
Nitrofurantoin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.00247	CcSEcCtD
Nitrofurantoin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00245	0.00245	CcSEcCtD
Nitrofurantoin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Nitrofurantoin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Nitrofurantoin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Nitrofurantoin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Nitrofurantoin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00239	0.00239	CcSEcCtD
Nitrofurantoin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.0023	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Nitrofurantoin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.002	0.002	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Nitrofurantoin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Nitrofurantoin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00179	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Nitrofurantoin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00169	0.00169	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00162	CcSEcCtD
Nitrofurantoin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00147	0.00147	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.00147	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00145	CcSEcCtD
Nitrofurantoin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Nitrofurantoin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Nitrofurantoin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Nitrofurantoin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Nitrofurantoin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Nitrofurantoin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Nitrofurantoin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Nitrofurantoin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Nitrofurantoin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Nitrofurantoin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Nitrofurantoin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Nitrofurantoin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Nitrofurantoin—Headache—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Nitrofurantoin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00096	0.00096	CcSEcCtD
